Hemophagocytic lymphohistiocytosis presenting as acute coronary syndrome.
Gabriel MelkiMina Fransawy AlkomosSushant M NanavatiVinod KumarChristina MariyamMichael MaroulesPublished in: Autopsy & case reports (2021)
Acquired Hemophagocytic Lymphohistiocytosis is a rare and deadly syndrome resulting from an overactive immune system, with uncontrolled activation of macrophages and lymphocytes, hypercytokinemia, and systemic inflammatory response. A 75-year-old male presented with typical anginal pain and was diagnosed with the acute coronary syndrome, which required a percutaneous transluminal coronary angioplasty. Instead of resolving the symptoms, the patient began to exhibit pyrexia and worsening altered sensorium with progressing renal failure, anemia, thrombocytopenia and respiratory failure. This constellation of symptoms caused the patient to require mechanical ventilation and hemodialysis. Upon laboratory analysis, hyperferritinemia provided an indication to the diagnosis of acquired hemophagocytic lymphohistiocytosis. After the initiation of dexamethasone, the patient made a significant recovery and was discharged from the hospital.
Keyphrases
- mechanical ventilation
- acute coronary syndrome
- respiratory failure
- case report
- inflammatory response
- acute respiratory distress syndrome
- intensive care unit
- extracorporeal membrane oxygenation
- chronic kidney disease
- percutaneous coronary intervention
- chronic pain
- coronary artery
- antiplatelet therapy
- healthcare
- low dose
- peripheral blood
- emergency department
- heart failure
- minimally invasive
- spinal cord injury
- immune response
- neuropathic pain
- left ventricular
- physical activity
- radiofrequency ablation
- iron deficiency